Data / Drug companies / KW Absc, Inc.
KW Absc, Inc.: 14 products in the FDA NDC directory, labeler code 69231
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
KW Absc, Inc. (labeler code 69231) lists 14 products in the FDA National Drug Code Directory, covering 2 finished drugs by generic name. By type: 14 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on November 9, 2022.
The request: Watch KW Absc, Inc. (FDA labeler code 69231): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 69231
- Products in commercial distribution
- 14
- Packages
- 14
- Finished drugs by generic name
- 2
- Prescription products
- 0
- Over the counter products
- 14
- Flagged as original packager
- 14 of 14 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- November 23, 2018
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 14 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 14 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Titanium dioxide, octinoxate, octisalate | 12 | 2 |
| Titanium dioxide, octinoxate, octisalate, avobenzone | 2 | 1 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 14 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| CLE CCC Neutral Deep | 69231-036 | Cream | Over the counter monograph drugs | November 9, 2022 |
| CLE CCC Warm Deep | 69231-032 | Cream | Over the counter monograph drugs | November 8, 2022 |
| CLE CCC Olive Medium Deep | 69231-035 | Cream | Over the counter monograph drugs | October 25, 2022 |
| CLE CCC Golden Medium | 69231-034 | Cream | Over the counter monograph drugs | October 25, 2022 |
| CLE CCC Neutral Fair | 69231-033 | Cream | Over the counter monograph drugs | October 24, 2022 |
| CLE CCC Cool Medium Deep | 69231-031 | Cream | Over the counter monograph drugs | October 24, 2022 |
| CLE CCC Neutral Medium | 69231-030 | Cream | Over the counter monograph drugs | October 18, 2022 |
| CLE CCC Neutral Medium Light | 69231-029 | Cream | Over the counter monograph drugs | October 18, 2022 |
| CLE CCC Neutral Light | 69231-028 | Cream | Over the counter monograph drugs | October 18, 2022 |
| CLE CCC Golden Medium Deep | 69231-027 | Cream | Over the counter monograph drugs | December 3, 2018 |
| CLE CCC Warm Medium Deep | 69231-026 | Cream | Over the counter monograph drugs | November 29, 2018 |
| CLE CCC Warm Medium | 69231-025 | Cream | Over the counter monograph drugs | November 27, 2018 |
| CLE CCC Warm Medium Light | 69231-024 | Cream | Over the counter monograph drugs | November 27, 2018 |
| CLE CCC Warm Light | 69231-023 | Cream | Over the counter monograph drugs | November 23, 2018 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.